Belati, A.; Bavaro, D.F.; Diella, L.; De Gennaro, N.; Di Gennaro, F.; Saracino, A.
Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae: A Retrospective Case Series and Literature Review. Antibiotics 2022, 11, 373.
https://doi.org/10.3390/antibiotics11030373
AMA Style
Belati A, Bavaro DF, Diella L, De Gennaro N, Di Gennaro F, Saracino A.
Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae: A Retrospective Case Series and Literature Review. Antibiotics. 2022; 11(3):373.
https://doi.org/10.3390/antibiotics11030373
Chicago/Turabian Style
Belati, Alessandra, Davide Fiore Bavaro, Lucia Diella, Nicolò De Gennaro, Francesco Di Gennaro, and Annalisa Saracino.
2022. "Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae: A Retrospective Case Series and Literature Review" Antibiotics 11, no. 3: 373.
https://doi.org/10.3390/antibiotics11030373
APA Style
Belati, A., Bavaro, D. F., Diella, L., De Gennaro, N., Di Gennaro, F., & Saracino, A.
(2022). Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae: A Retrospective Case Series and Literature Review. Antibiotics, 11(3), 373.
https://doi.org/10.3390/antibiotics11030373
